"Teradyne � We expect the company to report in line with our earnings projections of $0.83. Capacity constraints in high end logic testers, should be offset by strength in other segments to achieve the in-line results. � The hotly debated quarterly bookings will be the key.
We believe that given the highly back-end of the quarter nature of Teradyne�s bookings, weakness in Taiwan tester orders, and normal lumpiness of the tester business, that orders will be in the ball park of last quarter�s $826 million. However whether they are slightly above or below that level is hard to call."